The Liver Meeting 2021-AASLD/Japan Society of Hepatology Joint Symposium

Video Transcription

Video Summary

In summary, the video presentation discussed the increasing prevalence of non-alcoholic fatty liver disease (NAFLD) and its relationship with hepatocellular carcinoma (HCC) in Japan and the United States. The speakers highlighted the importance of accurately diagnosing liver fibrosis in NAFLD patients and the increased risk of HCC in those with advanced fibrosis or cirrhosis. Strategies for surveillance and screening for HCC in NAFLD patients were discussed, including the use of biomarkers such as FIP-4 and Fibroscan to identify high-risk individuals. The presentations underscored the complexity and heterogeneity of non-viral HCC, with factors like obesity, diabetes, alcohol consumption, and metabolic syndrome playing significant roles in the development of liver cancer. Overall, the talks provided valuable insights into the epidemiology, risk factors, and screening strategies for NAFLD-related HCC, paving the way for future research and clinical management in this important area.

Keywords

non-alcoholic fatty liver disease

NAFLD

hepatocellular carcinoma

HCC

liver fibrosis

cirrhosis

surveillance

screening

biomarkers

FIP-4

Fibroscan

metabolic syndrome